Loratadine and pseudoephedrine pharmacology
Pro Research Analysisby 
Searched over 200M research papers
Loratadine and Pseudoephedrine Pharmacology Overview
Loratadine and pseudoephedrine are commonly combined to treat symptoms of allergic rhinitis and the common cold. Loratadine is a long-acting, nonsedating antihistamine that blocks histamine H1 receptors, while pseudoephedrine is a sympathomimetic amine that acts as a decongestant by constricting blood vessels in the nasal passages 49.
Pharmacokinetics of Loratadine and Pseudoephedrine
Absorption and Metabolism
Loratadine is rapidly absorbed after oral administration and is extensively metabolized in the liver to its active metabolite, descarboethoxyloratadine (DCL). Pseudoephedrine is also well absorbed and acts quickly, but its effects are extended when formulated in modified-release tablets 1234+2 MORE.
Single vs. Multiple Dosing
Studies show that both single and multiple doses of loratadine and pseudoephedrine, whether given once daily or twice daily, result in similar overall exposure (AUC) for both drugs and their metabolites. The pharmacokinetics of loratadine are linear, and there is no significant accumulation or change in absorption when combined with pseudoephedrine or paracetamol in sustained-release formulations 123.
Food Effects
Food intake can increase the peak concentration and overall exposure of loratadine, but this increase is not clinically significant. Pseudoephedrine’s absorption and bioavailability are not affected by food .
Efficacy and Safety of Loratadine-Pseudoephedrine Combinations
Symptom Relief
The combination of loratadine and pseudoephedrine is effective in relieving both nasal and non-nasal symptoms of allergic rhinitis and the common cold. It is superior to placebo and as effective as combinations with classic antihistamines, but with fewer sedative side effects 56810.
Side Effects and Tolerability
Loratadine-pseudoephedrine combinations are generally well tolerated. The most common side effects are dry mouth, insomnia, and nervousness, but these occur less frequently than with older antihistamine combinations. Sedation is rare, and the risk of insomnia may be lower with once-daily formulations due to lower evening pseudoephedrine levels 15810.
Dosing Convenience
Once-daily and twice-daily formulations are equally effective, but once-daily dosing improves patient compliance without increasing adverse events 16.
Modified-Release Formulations
Modified-release tablets are designed to provide immediate relief with loratadine and part of the pseudoephedrine dose, while the remaining pseudoephedrine is released gradually for prolonged effect. This approach ensures sustained symptom control and reduces the need for frequent dosing 19.
Conclusion
Loratadine and pseudoephedrine, when used together, offer effective and well-tolerated relief for allergic rhinitis and cold symptoms. Their pharmacokinetic profiles are stable across different dosing regimens and are not significantly affected by food or co-administration with other common drugs. Modified-release formulations further enhance convenience and compliance, making this combination a preferred choice for many patients 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic